Beneficial effects of fish oil-based lipid emulsions on liver function within the scope of parenteral nutrition

Nutritional Therapy and Metabolism

Volumn 27, Issue 4, 2009, Pages 164-174

  Schlotzer, E ^a  

^a Fresenius Kabi   (Germany)

Author keywords

Fatty acids; Fish oil; Liver dysfunction; Omega 3; Parenteral nutrition; Short bowel syndrome; Soybean oil

Indexed keywords

GLYCINE MAX;

EID: 77953723675     PISSN: 18286232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 2006; 43: 9-19.
2. Fulford A, Scolapio JS, Aranda-Michel J. Parenteral nutrition-associated hepatotoxicity. Nutr Clin Pract 2004; 19: 274-83.
3. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 1968; 64: 134-42.
4. Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition. J Pediatr 1971; 78: 180-1.
5. Guglielmi FW, Moran Penco JM, Gentile A, et al. Hepatobiliary complications of longterm home parenteral nutrition. Clin Nutr 2001; 20: 51-5.
6. Grau T, Bonet A, Rubio M, et al. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 2007; 11: R10.
7. Grau T, Bonet A. Caloric intake and liver dysfunction in critically ill patients. Curr Opin Clin Nutr Metab Care 2009; 12: 175-9.
8. Guglielmi FW, Regano N, Mazzuoli S, et al. Cholestasis induced by total parenteral nutrition. Clin Liver Dis 2008; 12: 97-110.
9. Colomb V Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000; 24: 345-50.
10. Antebi H, Mansoor O, Ferrier C, et al. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. JPEN J Parenter Enteral Nutr 2004; 28: 142-8.
11. Heller AR, Rossel T, Gottschlich B, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004; 111: 611-6.
12. Piper A, Beschmann RB, Schade I. Hepatocellular integrity in patients requiring parenteral nutrition: comparison of a fish oil containing new lipid emulsion versus a lipid emulsion based on olive and soybean oil. Clin Nutr Suppl 2008; 3 (Supplement 1): 136.
13. Tomsits E, Pataki M, Tölgysi A, Fekete G, Rischak K, Szollar L. Safety and efficacy of a lipid emulsion containing a mixture of soybean, olive, coconut and fish oils: a randomized, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr 2009 (in press).
14. Goulet O, Antebi H, Wolf C, Alcindor LG, Corioll O, Colomb V. A new intravenous fat emulsion containing fish oil: a single-center double-blind randomized study on long-term efficacy and safety in pediatric patients. JPEN J Parenter Enteral Nutr 2008; 32: 316.
15. Diamond IR, Sterescu A, Pencharz PB, Wales PW. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int 2008; 24: 773-8.
16. Erlinger S. [Hepatic and biliary complications of parenteral feeding] [article in French]. Gastroenterol Clin Biol 1982; 6: 671-2.
17. Baker AL, Rosenberg IH. Hepatic complications of total parenteral nutrition. Am J Med 1987; 82: 489-97.
18. Guglielmi FW, Boggio-Bertinet D, Federico A, et al. Total parenteral nutrition-related gastroenterological complications. Dig Liver Dis 2006; 38: 623-42.
19. Drongowski RA, Coran AG. An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis. JPEN J Parenter Enteral Nutr 1989; 13: 586-9.
20. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000; 132: 525-32.
21. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998; 27: 131-7.
22. Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol 2007; 27: 284-90.
23. ASPEN. Guidelines for the use of parenteral and enteral nutrition in adult and paediatric patients. JPEN J Parenter Enteral Nutr 2002; 26: 1SA-138SA.
24. Cerra FB. Hepatobiliary complications of parenteral nutrition. In: Rombeau JL, Rolandelli RH, eds. Enteral and tube feeding. Philadelphia: WB Saunders, 1997; 141-56.
25. Wales PW, de Silva N, Kim J, Lecce L, To T, Moore A. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg 2004; 39: 690-5.
26. Andorsky DJ, Lund DP, Lillehei CW, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001; 139: 27-33.
27. Warner BW, Ziegler MM. Management of the short bowel syndrome in the pediatric population. Pediatr Clin North Am 1993; 40: 1335-50.
28. Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 2005; 40: 755-62.
29. Angelico M, Della GP. Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther 2000; 14 (Suppl 2): 54-7.
30. Teitelbaum DH, Tracy T. Parenteral nutrition-associated cholestasis. Semin Pediatr Surg 2001; 10: 72-80.
31. Javid PJ, Collier S, Richardson D, et al. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg 2005; 40: 1015-8.
32. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121: e678-86.
33. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006; 83: 1467S-76S.
34. Van Aerde JE, Duerksen DR, Gramlich L, et al. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res 1999; 45: 202-8.
35. Alwayn IP, Gura K, Nose V et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 2005; 57: 445-52.
36. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83: 1505S-19S.
37. Mayer K, Schaefer MB, Seeger W. Fish oil in the critically ill: from experimental to clinical data. Curr Opin Clin Nutr Metab Care 2006; 9: 140-8.
38. Aprahamian CJ, Chen M, Yang Y, Lorenz RG, Harmon CM. Two-hit rat model of short bowel syndrome and sepsis: independent of total parenteral nutrition, short bowel syndrome is proinflammatory and injurious to the liver. J Pediatr Surg 2007; 42: 992-7.
39. Moschen AR, Tilg H. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2008; 11: 620-5.
40. Weinberger B, Watorek K, Strauss R, Witz G, Hiatt M, Hegyi T. Association of lipid peroxidation with hepatocellular injury in preterm infants. Crit Care 2002; 6: 521-5.
41. Van Gossum A, Shariff R, Lemoyne M, Kurian R, Jeejeebhoy K. Increased lipid peroxidation after lipid infusion as measured by breath pentane output. Am J Clin Nutr 1988; 48: 1394-9.
42. Pitkanen OM. Peroxidation of lipid emulsions: a hazard for the premature infant receiving parenteral nutrition? Free Radic Biol Med 1992; 13: 239-45.
43. Linseisen J, Hoffmann J, Lienhard S, Jauch KW, Wolfram G. Antioxidant status of surgical patients receiving TPN with an omega-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol. Clin Nutr 2000; 19: 177-84.
44. Schlotzer E, Kanning U. Elimination and tolerance of a new parenteral lipid emulsion (SMOF): a double-blind cross-over study in healthy male volunteers. Ann Nutr Metab 2004; 48: 263-8.
45. Mertes N, Grimm H, Furst P, Stehle P. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid®) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 2006; 50: 253-9.
46. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993; 105: 1806-13.
47. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998; 14: 158-64.
48. Ellegard L, Sunesson A, Bosaeus I. High serum phytosterol levels in short bowel patients on parenteral nutrition support. Clin Nutr 2005; 24: 415-20.
49. Hallikainen M, Huikko L, Kontra K, et al. Effect of parenteral serum plant sterols on liver enzymes and cholesterol metabolism in a patient with short bowel syndrome. Nutr Clin Pract 2008; 23: 429-35.
50. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
51. Falconer JS, Fearon KC, Ross JA, et al. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 1995; 75: 2077-82.
52. Hosotsubo KK, Nishimura M, Nishimura S. Hyperbilirubinaemia after major thoracic surgery: comparison between open-heart surgery and oesophagectomy. Crit Care 2000; 4: 180-7.
53. Pscheidl E, Schywalsky M, Tschaikowsky K, Boke-Prols T. Fish oil-supplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model. Crit Care Med 2000; 28: 1489-96.
54. Heller AR, Theilen HJ, Koch T. Fish or chips? News Physiol Sci 2003; 18: 50-4.
55. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: Omegaven® for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009; 48: 209-15.
56. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006; 118: e197-e201.
57. Ekema G, Falchetti D, Boroni G, et al. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (omega-3 fatty acids). J Pediatr Surg 2008; 43: 1191-5.
58. Cheung HM, Lam HS, Tam YH, Lee KH, Ng PC. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr 2009; 28: 209-12.
59. Rafeeq M, Bremner R, Davies P, et al. A sudden and marked reduction in PN cholestasis on changing from a conventional intravenous lipid source to SMOFlipid. In: Campbell D, Conolly S, Taylor C, Thomson M, eds. Proceedings of the winter meeting of the British Society of Paediatric Gastroenterology, Hepatology and Nutrition. 2009: 53.
60. Ferreira N, Falconer J, Harley C, Rawat D, Fell J, Koglmeier J. Improved serum bilirubin with SMOFlipid® in children with intestinal failure on long term parenteral nutrition. In: Campbell D, Conolly S, Taylor C, Thomson M, eds. Proceedings of the winter meeting of the British Society of Paediatric Gastroenterology, Hepatology and Nutrition. 2009: 73.